Non-statin cholesterol drugs on Prescription Blue Premium (S5584-002)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Michigan
- Premium
- $106.70/month
- Deductible
- None
6 of 8 Non-statin cholesterol drugs are covered on this plan. 3 of them require prior authorization.
2 aren't on the formulary (Repatha and Vascepa).
- $1.03Tier 3
- from $124.48Tier 3
- $109.96Tier 4
- $109.78Tier 4
- from $0.95Tier 3
- 27%Tier 4
Not on the formulary
Repatha, Vascepa
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.